Top

Published in:

01-08-2020 | Thyroidectomy | Original Article

Noninvasive follicular neoplasm with papillary-like nuclear features (NIFTP): a 13-year retrospective review at Jordan University Hospital

Authors: Rajai O. Zurikat, Majd Khader, Muayad I. Azzam, Zaid M. Zahid, Samer F. Daoud, Salam F. Nusirat, Nader Albsoul, Motaz A. Al-Natsheh, Mousa A. Al-Abbadi

Published in: Endocrine | Issue 2/2020

Abstract

Objective

Noninvasive follicular neoplasm with papillary-like nuclear features (NIFTP) is the term to describe what was previously known as encapsulated follicular variant of papillary thyroid carcinoma. This new paradigm shift was agreed upon by experts in the field. The objective of this study is to evaluate cases previously diagnosed as follicular adenomas, follicular variant of papillary thyroid carcinoma and hyperplastic nodules to be reclassified as NIFTP according to the new criteria. Furthermore, the clinical follow-up of these NIFTP cases is evaluated.

Methods

This retrospective study reviewed potential NIFTP cases over the last 13 years, at Jordan University Hospital.

Results

A total of 811 thyroid surgery reports were identified and revised to identify the potential NIFTP cases. The review yielded 173 cases identified as potential NIFTP cases. Further pathological slide review resulted in a revised diagnosis of 32 cases of NIFTP according to the new criteria. The NIFTP cases comprised 4% of the total number of thyroidectomy cases and 16.1% of the total pool of previously diagnosed papillary thyroid carcinoma cases at our institution. While 111 cases retained their original diagnosis. Follow-up showed that all patients are alive and well with no evidence of disease.

Conclusion

Patients with NIFTP are not uncommon and the diagnosis is made only after a thorough evaluation of excision. Therefore, initial conservative management of solitary thyroid nodules suspicious for NIFTP in the form of lobectomy is recommended to avoid unnecessary total thyroidectomies. Our follow-up of NIFTP cases is similar to all previous reports.

V. Chaudhary, S. Bano, Thyroid ultrasound. Indian J. Endocrinol. Metab. 17, 219–227 (2013). https://doi.org/10.4103/2230-8210.109667 CrossRefPubMedPubMedCentral

D.S. Dean, H. Gharib, Epidemiology of thyroid nodules. Best. Pract. Res Clin. Endocrinol. Metab. 22, 901–911 (2008)CrossRef

D.J. Finley, B. Zhu, C.B. Barden, T.J. Fahey III, Discrimination of benign and malignant thyroid nodules by molecular profiling. Ann. Surg. 240, 425–436 (2004). discussion 436-7CrossRef

J. Yang, V. Schnadig, R. Logrono, P.G. Wasserman, Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 111, 306–315 (2007). https://doi.org/10.1002/cncr.22955 CrossRefPubMed

H. Gharib, Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin. Proc. 69, 44–49 (1994)CrossRef

H. Gharib, J.R. Goellner, Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann. Intern. Med. 118, 282–289 (1993)CrossRef

S.I. Sherman, Thyroid carcinoma. Lancet 361, 501–511 (2003)CrossRef

J.J. Wiltshire, T.M. Drake, L. Uttley, S.P. Balasubramanian, Systematic review of trends in the incidence rates of thyroid cancer. Thyroid (2016). https://doi.org/10.1089/thy.2016.0100

J.R. Burgess, P. Tucker, Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroid 16, 47–53 (2006). https://doi.org/10.1089/thy.2006.16.47 CrossRefPubMed

10.

M.H. Hajeer, H.A. Awad, N.I. Abdullah, G.H. Almuhaisen, L.E. Abudalu, The rising trend in papillary thyroid carcinoma: true increase or over diagnosis? Saudi Med. J. 39, 147–153 (2018). https://doi.org/10.15537/smj.2018.2.21211 CrossRefPubMedPubMedCentral

11.

A. Ogbera, S. Kuku, Epidemiology of thyroid diseases in Africa. Indian J. Endocrinol. Metab. (2011). https://doi.org/10.4103/2230-8210.83331

12.

S.I. Sherman, P. Angelos, D.W. Ball, D. Byrd, O.H. Clark, G.H. Daniels, R.A. Dilawari, H. Ehya, W.B. Farrar, R.F. Gagel, F. Kandeel, R.T. Kloos, P. Kopp, D.M. Lamonica, T.R. Loree, W.M. Lydiatt, J. McCaffrey, J.A. Olson, J.A. Ridge, J.P. Shah, J.C. Sisson, R.M. Tuttle, M.M. Urist, Thyroid carcinoma. J. Natl Compr. Cancer Netw. (2007)

13.

J. Drábek, J. Gatek, J. Lukas, J. Drabek, D. Lukas, L. Dusek, The epidemiology of thyroid cancer in the Czech Republic in comparison with other countries. Biomed. Pap. Med Fac. Univ. Palacky. Olomouc Czech Repub. 157, 266–275 (2012). https://doi.org/10.5507/bp.2012.086 CrossRefPubMed

14.

M. Kim, M.J. Jeon, H.-S. Oh, S. Park, T.Y. Kim, Y.K. Shong, W.B. Kim, K. Kim, W.G. Kim, D.E. Song, BRAF and RAS mutational status in noninvasive follicular thyroid neoplasm with papillary-like nuclear features and invasive subtype of encapsulated follicular variant of papillary thyroid carcinoma in Korea. Thyroid 28, 504–510 (2018). https://doi.org/10.1089/thy.2017.0382 CrossRefPubMed

15.

Z. Liu, A. Bychkov, C.K. Jung, M. Hirokawa, S. Sui, S.W. Hong, C.R. Lai, D. Jain, S. Canberk, K. Kakudo, Interobserver and intraobserver variation in the morphological evaluation of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice. Pathol. Int. 69, 202–210 (2019). https://doi.org/10.1111/pin.12779 CrossRefPubMed

16.

Y. Ito, A. Miyauchi, M. Kihara, M. Fukushima, T. Higashiyama, A. Miya, Overall survival of papillary thyroid carcinoma patients: a single-institution long-term follow-up of 5897 patients. World J. Surg. (2018). https://doi.org/10.1007/s00268-018-4479-z

17.

S.O. Sebastian, J.M.R. Gonzalez, P.P. Paricio, J.S. Perez, D.P. Flores, A.P. Madrona, P.R. Romero, F.J. Tebar, Papillary thyroid carcinoma. Arch. Surg. 135, 272 (2000). https://doi.org/10.1001/archsurg.135.3.272 CrossRefPubMed

18.

E.L. Mazzaferri, R.L. Young, Papillary thyroid carcinoma: a 10 year foliow-up report of the impact of therapy in 576 patients. Am. J. Med. (1981). https://doi.org/10.1016/0002-9343(81)90573-8

19.

S.A. Hundahl, I.D. Fleming, A.M. Fremgen, H.R. Menck, A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer 83, 2638–2648 (1998). https://doi.org/10.1002/(sici)1097-0142(19981215)83:123.0.co;2-1

20.

R. Rahbari, L. Zhang, E. Kebebew, Thyroid cancer gender disparity. Future Oncol. 6, 1771–1779 (2010). https://doi.org/10.2217/fon.10.127 CrossRefPubMedPubMedCentral

21.

S. Lindsay, Carcinoma of the thyroid gland: a clinical and pathologic study of 293 patients at the University of California Hospital. Calif. Med. 93(4), 261 (1960)

22.

A.K.Y. Lam, C.Y. Lo, K.S.L. Lam, Papillary carcinoma of thyroid: a 30-yr clinicopathological review of the histological variants. Endocr. Pathol. 16, 323–330 (2005)CrossRef

23.

M.J. Kim, J.-K. Won, K.C. Jung, J. Kim, S.W. Cho, D.J. Park, Y.J. Park, Clinical characteristics of subtypes of follicular variant papillary thyroid carcinoma. Thyroid. 28, 311–318 (2018). https://doi.org/10.1089/thy.2016.0671

24.

S. Gupta, O. Ajise, L. Dultz, B. Wang, D. Nonaka, J. Ogilvie, K.S. Heller, K.N. Patel, Follicular variant of papillary thyroid cancer: encapsulated, nonencapsulated, and diffuse: distinct biologic and clinical entities. Arch. Otolaryngol. Neck Surg. 138, 227 (2012). https://doi.org/10.1001/archoto.2011.1466 CrossRef

25.

J. Liu, B. Singh, G. Tallini, D.L. Carlson, N. Katabi, A. Shaha, R.M. Tuttle, R.A. Ghossein, Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer. (2006). https://doi.org/10.1002/cncr.22138

26.

Y.E. Nikiforov, R.R. Seethala, G. Tallini, Z.W. Baloch, F. Basolo, L.D.R. Thompson, J.A. Barletta, B.M. Wenig, A. Al Ghuzlan, K. Kakudo, T.J. Giordano, V.A. Alves, E. Khanafshar, S.L. Asa, A.K. El-Naggar, W.E. Gooding, S.P. Hodak, R.V. Lloyd, G. Maytal, O. Mete, M.N. Nikiforova, V. Nosé, M. Papotti, D.N. Poller, P.M. Sadow, A.S. Tischler, T.R. Michael, K.B. Wall, V.A. LiVolsi, G.W. Randolph, R.A. Ghossein, Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. (2016). https://doi.org/10.1001/jamaoncol.2016.0386

27.

Y.E. Nikiforov, Z.W. Baloch, S.P. Hodak, T.J. Giordano, R.V. Lloyd, R.R. Seethala, B.M. Wenig, Change in diagnostic criteria for noninvasive follicular thyroid neoplasm with papillarylike nuclear features. JAMA Oncol. (2018)

28.

D. Fonseca, S. Bhuyan, SS. Murthy, V. Rao, C. Rao, KVVN. Raju, C. Sundaram, Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a distinct clinicopathologic entity. Indian J. Pathol. Microbiol. 61, 380–382 (2018)CrossRef

29.

L.D.R. Thompson, D.N. Poller, K. Kakudo, R. Burchette, Y.E. Nikiforov, R.R. Seethala, An international interobserver variability reporting of the nuclear scoring criteria to diagnose noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a validation study. Endocr. Pathol. 29, 242–249 (2018). https://doi.org/10.1007/s12022-018-9520-0 CrossRefPubMed

30.

A. Bychkov, S. Keelawat, S. Agarwal, D. Jain, C.K. Jung, S.W. Hong, C.R. Lai, S. Satoh, K. Kakudo, Impact of non-invasive follicular thyroid neoplasm with papillary-like nuclear features on the Bethesda system for reporting thyroid cytopathology: a multi-institutional study in five Asian countries. Pathology 50, 411–417 (2018). https://doi.org/10.1016/j.pathol.2017.11.088 CrossRefPubMed

31.

W.C. Faquin, L.Q. Wong, A.H. Afrogheh, S.Z. Ali, J.A. Bishop, M. Bongiovanni, M.P. Pusztaszeri, C.J. VandenBussche, J. Gourmaud, L.J. Vaickus, Z.W. Baloch, Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology. Cancer Cytopathol. 124, 181–187 (2016). https://doi.org/10.1002/cncy.21631 CrossRefPubMed

32.

F. Maletta, F. Massa, L. Torregrossa, E. Duregon, G.P. Casadei, F. Basolo, G. Tallini, M. Volante, Y.E. Nikiforov, M. Papotti, Cytological features of “noninvasive follicular thyroid neoplasm with papillary-like nuclear features” and their correlation with tumor histology. Hum. Pathol. 54, 134–142 (2016). https://doi.org/10.1016/J.HUMPATH.2016.03.014 CrossRefPubMed

33.

Z.W. Baloch, R.R. Seethala, W.C. Faquin, M.G. Papotti, F. Basolo, G. Fadda, G.W. Randolph, S.P. Hodak, Y.E. Nikiforov, S.J. Mandel, Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a changing paradigm in thyroid surgical pathology and implications for thyroid cytopathology. Cancer Cytopathol. 124, 616–620 (2016). https://doi.org/10.1002/cncy.21744 CrossRefPubMed

34.

J.F. Krane, E.K. Alexander, E.S. Cibas, J.A. Barletta, Coming to terms with NIFTP: a provisional approach for cytologists. Cancer Cytopathol. 124, 767–772 (2016). https://doi.org/10.1002/cncy.21769 CrossRefPubMed

35.

V.A.F. Alves, K. Kakudo, V. LiVolsi, R.V. Lloyd, Y.E. Nikiforov, V. Nosé, M. Papotti, L.D.R. Thompson, Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): achieving better agreement by refining diagnostic criteria. Clin. 73, e576 (2018). https://doi.org/10.6061/clinics/2018/e576 CrossRef

36.

V.A. Paulson, P. Shivdasani, T.E. Angell, E.S. Cibas, J.F. Krane, N.I. Lindeman, E.K. Alexander, J.A. Barletta, Noninvasive follicular thyroid neoplasm with papillary-like nuclear features accounts for more than half of “carcinomas” harboring RAS mutations. Thyroid 27, 506–511 (2017). https://doi.org/10.1089/thy.2016.0583 CrossRefPubMed

37.

L. Zhao, D. Dias-Santagata, P.M. Sadow, W.C. Faquin, Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma. Cancer Cytopathol. 125, 323–331 (2017). https://doi.org/10.1002/cncy.21839 CrossRefPubMed

38.

K.P. Du Jour, A.C. Schmitt, A.Y. Chen, C.C. Griffith, Application of strict criteria for noninvasive follicular thyroid neoplasm with papillary-like nuclear features and encapsulated follicular variant papillary thyroid carcinoma: a retrospective study of 50 tumors previously diagnosed as follicular variant PTC. Endocr. Pathol. 29, 35–42 (2018)CrossRef

39.

T.C. Brandler, F. Zhou, C.Z. Liu, M. Cho, R.P. Lau, A. Simsir, K.N. Patel, W. Sun, Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration? Cancer Cytopathol. 125, 378–388 (2017). https://doi.org/10.1002/cncy.21848 CrossRefPubMed

40.

J.B. Chandler, M. Colunga, M.L. Prasad, G.G. Callender, C. Quinn, D. Chhieng, A.J. Adeniran, Identification of distinct cytomorphologic features in the diagnosis of NIFTP at the time of preoperative FNA: implications for patient management. Cancer Cytopathol. 125, 865–875 (2017). https://doi.org/10.1002/cncy.21910 CrossRefPubMed

41.

S.-H. You, K.E. Lee, R.-E. Yoo, H.J. Choi, K.C. Jung, J.-K. Won, K.M. Kang, T.J. Yoon, S.H. Choi, C.-H. Sohn, J. Kim, Prevention of total thyroidectomy in noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) based on combined interpretation of ultrasonographic and cytopathologic results. Clin. Endocrinol. 88, 114–122 (2018). https://doi.org/10.1111/cen.13473 CrossRef

42.

P.W. Rosario, G.F. Mourão, Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a review for clinicians. Endocr. Relat. Cancer 26, R259–R266 (2019). https://doi.org/10.1530/ERC-19-0048 CrossRefPubMed

43.

R.T. Shrestha, D. Ruanpeng, J.V. Hennessey, Cytomorphology of noninvasive follicular thyroid neoplasm with papillary-like nuclear features and the impact of new nomenclature on molecular testing. Med. Sci. 7, 15 (2019). https://doi.org/10.3390/medsci7020015 CrossRef

44.

H.G. Vuong, T.T.K. Tran, A. Bychkov, C.K. Jung, T. Nakazawa, K. Kakudo, R. Katoh, T. Kondo, Clinical impact of non-invasive follicular thyroid neoplasm with papillary-like nuclear features on the risk of malignancy in the Bethesda System for reporting thyroid cytopathology: a meta-analysis of 14,153 resected thyroid nodules. (2019)

Title: Noninvasive follicular neoplasm with papillary-like nuclear features (NIFTP): a 13-year retrospective review at Jordan University Hospital
Authors: Rajai O. Zurikat
Majd Khader
Muayad I. Azzam
Zaid M. Zahid
Samer F. Daoud
Salam F. Nusirat
Nader Albsoul
Motaz A. Al-Natsheh
Mousa A. Al-Abbadi
Publication date: 01-08-2020
Publisher: Springer US
Keywords: Thyroidectomy
Thyroidectomy
Published in: Endocrine / Issue 2/2020
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-020-02299-0

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2020

Comparison of different systems of ultrasound (US) risk stratification for malignancy in elderly patients with thyroid nodules. Real world experience

From an out-of-date experience

Correction to: Androgen receptor regulates expression of skeletal muscle–specific proteins and muscle cell types

Albumin binding function is a novel biomarker for early liver damage and disease progression in non-alcoholic fatty liver disease

Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective

Global burden of noncommunicable disease attributable to high body mass index in 195 countries and territories, 1990–2017

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage